Last reviewed · How we verify

NCT03529838

Hemodynamic and Salivary Responses of 12 Weeks of Training With Different Anti-hypertensive

Terminated NA Last updated 22 March 2022
What this trial tests

NA trial testing Combined exercise in Hypertension in 30 participants. Terminated before completion.

Timeline
1 March 2017
Primary endpoint
1 March 2019
1 March 2021

Quick facts

Lead sponsorFederal University of Uberlandia
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment30
Start date1 March 2017
Primary completion1 March 2019
Estimated completion1 March 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of Uberlandia

Who can join

Adults 50 to 70, female only, with Hypertension or Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Different classes of antihypertensives may have different responses when associated with exercise. Thus, this study aims to compare the responses of the association of 12 weeks of aerobic exercise and weightlifting with different classes of medications in 45 postmenopausal hypertensive women.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Different cardiovascular responses to exercise training in hypertensive women receiving β-blockers or angiotensin receptor blockers: A pilot study.
    Mariano IM, Amaral AL, V Carrijo VH, Costa JG, et al · · 2022 · cited 1× · PMID 35465803 · DOI 10.1080/10641963.2022.2065290

Verify or expand the search:

Other trials of Combined exercise

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Federal University of Uberlandia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03529838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing